Graf Akcie CRSP (CRISPR Therapeutics AG). Diskuze k akciím CRSP. Aktuální informace CRSP.

Základní informace o společnosti CRISPR Therapeutics AG (Akcie CRSP)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 7.33B
Hodnota podniku (EV) 6.35B
Tržby 901.758M
EBITDA 459.184M
Zisk 446.584M
Růst v tržbách Q/Q 2,046,947.73 %
Růst v tržbách Y/Y 211.87 %
P/E (Cena vůči ziskům) 17.44
Forward P/E -0.83
EV/Sales 7.04
EV/EBITDA 13.82
EV/EBIT 14.06
PEG N/A
Price/Sales 8.13
P/FCF 14.60
Price/Book 4.41
Účetní hodnota na akcii 22.40
Hotovost na akcii 22.98
FCF vůči ceně 6.85 %
Počet zaměstnanců 410
Tržba na zaměstnance 2199000
Profit margin -48,520.86 %
Operating margin 49.67 %
Gross margin 100.00 %
EBIT margin 50.05 %
EBITDA margin 50.92 %
EPS - Zisk na akcii 5.66
EPS - Kvartální růst -826.15 %
EPS - Očekávaný růst příští rok 31.82 %
Return on assets 21.86 %
Return on equity 24.08 %
ROIC -24.05 %
ROCE 16.12 %
Dluhy/Equity 0.10
Čistý dluh/EBITDA -15.59
Current ratio 26.23
Quick Ratio 26.23
Volatilita 5.40
Beta 1.31
RSI 34.55
Cílová cena analytiků 103
Známka akcie (dle analytiků) 2.00
Insider ownership 12.96 %
Institutional ownership 58.24 %
Počet akcií 76.201M
Procento shortovaných akcií 4.93 %
Short ratio 1.82 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2016
Země Switzerland

Finanční výsledky akcie CRSP

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.719$289.59$3.124$40.997$5.164$0.247-
Cost Of Goods Sold-------
Gross Profit$0.719$289.59$3.124$40.997$5.164$0.247-
Research And Development Expenses$266.946$179.362$113.773$69.8$42.238$12.573$1.513
SG&A Expenses$88.208$63.488$48.294$35.845$31.056$13.403$5.114
Other Operating Income Or Expenses-------
Operating Expenses$355.154$242.85$162.067$105.645$73.294$25.976$6.627
Operating Income$-354.435$46.74$-158.943$-64.648$-68.13$-25.729$-6.627
Total Non-Operating Income/Expense$6.379$20.566$-5.485$-1.96$45.412$-0.092$-0.236
Pre-Tax Income$-348.056$67.306$-164.428$-66.608$-22.718$-25.821$-6.863
Income Taxes$0.809$0.448$0.553$1.749$0.484$0.007$-0.063
Income After Taxes$-348.865$66.858$-164.981$-68.357$-23.202$-25.828$-6.8
Other Income-------
Income From Continuous Operations$-348.865$66.858$-164.981$-68.357$-23.202$-25.828$-6.8
Income From Discontinued Operations-------
Net Income$-348.865$66.858$-164.981$-68.357$-23.177$-25.503$-7.009
EBITDA$-345.251$51.465$-155.424$-61.624$-67.205$-25.602$-6.589
EBIT$-354.435$46.74$-158.943$-64.648$-68.13$-25.729$-6.627
Basic Shares Outstanding665448401254
Shares Outstanding665748401254
Basic EPS$-5.29$1.23$-3.44$-1.71$-1.89$-5.06$-1.97
EPS - Earnings Per Share$-5.29$1.17$-3.44$-1.71$-1.89$-5.06$-1.97
# 2020 2019 2018 2017 2016 2015
Current Ratio18.211717.293216.809517.11714.555315.4446
Long-term Debt / Capital-----4.1615
Debt/Equity Ratio------1.3163
Gross Margin100100100100100100
Operating Margin-49295.5516.1401-5087.804-157.6896-1319.326-10416.6
EBIT Margin-49295.5516.1401-5087.804-157.6896-1319.326-10416.6
EBITDA Margin-48018.2317.7717-4975.16-150.3134-1301.414-10365.18
Pre-Tax Profit Margin-48408.3523.2418-5263.38-162.4704-439.9303-10453.85
Net Profit Margin-48520.8623.0871-5281.082-166.7366-448.8187-10325.1
Asset Turnover0.00040.27150.00640.15110.0150.0015
Inventory Turnover Ratio------
Receiveable Turnover4.99312925.15235.515.6121.63570.7286
Days Sales In Receivables73.10150.124810.281723.3795223.1419500.9514
ROE - Return On Equity-20.96257.1169-42.0661-36.3926-9.964588.6829
Return On Tangible Equity-20.96487.1187-42.0971-36.4594-9.9816-73.9147
ROA - Return On Assets-19.08496.2674-33.7373-25.1918-6.726-16.2009
ROI - Return On Investment-20.96257.1169-42.0661-36.3926-9.9645-280.3735
Book Value Per Share22.515515.45517.56364.62735.8622-5.2685
Operating Cash Flow Per Share-4.60983.002-0.25672.7625-16.309713.1438
Free Cash Flow Per Share-4.77082.9424-0.11942.8135-16.326712.9147